查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1741130

脑下垂体癌市场：依癌症类型、依荷尔蒙类型、依治疗类型、年龄层、依最终使用者、按地区

Pituitary Cancer Market, By Cancer Type, By Hormone Type, By Treatment Type, By Age Group, By End User, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3个工作天内

价格
简介目录

脑下垂体癌市场规模预计在 2025 年为 4.577 亿美元，预计到 2032 年将达到 8.695 亿美元，2025 年至 2032 年的复合年增长率为 9.6%。

报告范围 报告详细信息
基准年 2024 2025年的市场规模 4.577亿美元
效能数据 从2020年到2024年 预测期 2025年至2032年
预测期：2025-2032年复合年增长率： 9.60% 2032年价值预测 8.695亿美元

脑下垂体癌的病因尚不清楚；然而，遗传和荷尔蒙失衡可能起着一定作用。大多数脑下垂体肿瘤是腺瘤，这意味着它们是非癌性的。脑下垂体癌的发生率低于脑下垂体囊肿，后者是良性的（非癌性的）。

脑下垂体癌的常见症状包括头痛、视力下降、体重减轻或无法增加体重、记忆力下降和注意力下降。某些类型的脑下垂体肿瘤会分泌过多的激素，导致库欣氏症候群。这种疾病会导致催乳素分泌过量，使胸部和手臂皮肤变薄，腿部和臀部骨骼变得脆弱。即使女性没有怀孕，它也会导致乳房分泌乳汁。此外，它还可能导致各种血压变化，例如脸色潮红以及手臂和腿部血压升高。

市场动态：

脑下垂体瘤发生率的上升、研发投入的增加以及治疗方法的技术进步预计将在预测期内推动全球脑下垂体癌市场的成长。此外，民众认知度的提高也推动了对非侵入性治疗的需求。提供脑下垂体瘤专科服务的医院和诊所数量的增加也推动了市场的发展。

然而，预计癌症治疗的高成本是预测期内阻碍全球脑下垂体癌市场成长的主要因素。

本研究的主要特点

  • 本报告对全球脑下垂体癌市场进行了详细分析，并提供了预测期 2025-2032（以 2024 年为基准年）的市场规模和年复合成长率(CAGR%)。
  • 它还揭示了各个领域的潜在商机，并说明了该市场的引人注目的投资提案矩阵。
  • 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
  • 它根据公司亮点、产品系列、关键亮点、绩效和策略等参数，介绍了全球脑下垂体癌市场的主要企业概况。
  • 本报告的见解将使负责人和企业经营团队能够就未来的产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。
  • 全球脑下垂体癌市场报告迎合了该行业的各个相关人员，例如投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
  • 相关人员将透过用于分析全球脑下垂体癌市场的各种策略矩阵更轻鬆地做出决策。

目录

第一章 调查目的与前提条件

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告描述
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map（COM）

第三章市场动态、法规与趋势分析

  • 市场动态
    • 驱动程式
  • 发病率和盛行率不断上升
  • 医疗图像的进展
  • 加强研发
  • 个人化医疗需求日益增长
    • 限制因素
  • 缺乏认识和延迟诊断
  • 缺乏标准化的治疗指南
  • 进行性脑下垂体癌的治疗选择有限
  • 药物研发面临的挑战
    • 机会
  • 标靶治疗开发
  • 联合治疗
  • 外科技术的进步
  • 新型诊断影像方法的开发
  • 影响分析
  • 主要亮点
  • 监管情景
  • 产品发布/核准
  • PEST分析
  • 波特分析
  • 併购场景

第四章脑下垂体癌市场-冠状病毒（COVID-19）大流行的影响

  • COVID-19流行病学
  • 供需侧分析
  • 经济影响

5. 脑下垂体癌市场（依癌症类型划分），2020 年至 2032 年

  • 脑下垂体腺瘤（良性肿瘤）
  • 脑下垂体癌（恶性肿瘤）

6. 脑下垂体癌市场（依荷尔蒙类型划分），2020 年至 2032 年

  • 催乳素瘤
  • 生长激素分泌肿瘤（肢端肥大症）
  • 促肾上腺皮质激素分泌肿瘤（库欣氏症）
  • 甲状腺刺激素分泌肿瘤（TSHomas）
  • 促性腺激素分泌分泌肿瘤

7. 脑下垂体癌市场（依治疗类型划分），2020 年至 2032 年

  • 外科手术
  • 放射治疗
  • 药物治疗（例如多巴胺促效剂、生长抑制素类似物、荷尔蒙补充疗法）
  • 标靶治疗
  • 化疗

8. 脑下垂体癌市场（依年龄划分），2020 年至 2032 年

  • 孩子们
  • 成人

9. 脑下垂体癌市场（以最终用户划分），2020 年至 2032 年

  • 医院
  • 专科诊所
  • 癌症治疗中心
  • 研究机构

第 10 章 脑下垂体癌市场（按地区划分），2020 年至 2032 年

  • 北美洲
  • 美国
  • 加拿大
  • 欧洲
  • 英国
  • 德国
  • 义大利
  • 法国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • ASEAN
  • 澳洲
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
  • 中东和非洲
  • GCC
  • 以色列
  • 北非
  • 中部非洲
  • 其他中东和非洲地区

第十一章竞争格局

  • Novartis International AG
  • Pfizer Inc.
  • Ipsen Biopharmaceuticals, Inc.
  • Endocyte
  • RECORDATI GROUP
  • Camurus AB
  • Endeavor Biomedicines, Inc
  • Debiopharm International SA

第十二章 章节

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI5851

Pituitary Cancer Market is estimated to be valued at USD 457.7 Mn in 2025 and is expected to reach USD 869.5 Mn by 2032, growing at a compound annual growth rate (CAGR) of 9.6% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 457.7 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 9.60% 2032 Value Projection: USD 869.5 Mn

The cause of pituitary cancer is not well understood. But genetics and hormonal imbalances may play a role. Most pituitary tumors are adenomas, or noncancerous. They are not as common as pituitary gland cysts, which are benign (noncancerous).

Symptoms of pituitary cancer often include headaches, vision changes, loss of weight or an inability to gain weight, and trouble with memory and concentration. Some types of pituitary tumors release too many hormones, which can lead to a disease called Cushing's syndrome. In some cases, this disease causes the body to produce too much prolactin, which can cause thinning of the skin in the chest and arms, and weak bones in the legs and feet. Other forms of this condition can cause the breasts to make milk, even when the person is not pregnant. The condition can also cause a wide range of changes in blood pressure, including a flushed face and high blood pressure in the arms or legs.

Market Dynamics:

Rising incidences of pituitary tumors, increasing investments in research and development activities, and technological advancements in treatment methods are expected to drive growth of the global pituitary cancer market during the forecast period. In addition, increased awareness among the populace has led to a higher demand for noninvasive treatments. The market is also driven by a rise in the number of hospitals and clinics that offer specialized services for pituitary tumors.

However, the high cost of cancer treatments is a major factor expected to impede the growth of the global pituitary cancer market over the forecast period.

Key features of the study:

  • This report provides in-depth analysis of the global pituitary cancer market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global pituitary cancer market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Novartis International AG, Pfizer Inc., Ipsen Biopharmaceuticals, Inc., Endocyte, RECORDATI GROUP, Camurus AB, Endeavor Biomedicines, Inc., and Debiopharm International SA
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global pituitary cancer market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pituitary cancer market

Global Pituitary Cancer Market Detailed Segmentation:

  • By Cancer Type:
    • Pituitary Adenoma (Benign Tumor)
    • Pituitary Carcinoma (Malignant Tumor)
  • By Hormone Type:
    • Prolactinoma
    • Growth Hormone-Secreting Tumor (Acromegaly)
    • Adrenocorticotropic Hormone-Secreting Tumor (Cushing's Disease)
    • Thyroid-Stimulating Hormone-Secreting Tumor (TSHoma)
    • Gonadotropin-Secreting Tumor
  • By Treatment Type:
    • Surgery
    • Radiation Therapy
    • Medications (e.g., dopamine agonists, somatostatin analogs, hormone replacement therapy)
    • Targeted Therapy
    • Chemotherapy
  • By Age Group:
    • Pediatric
    • Adult
  • By End User:
    • Hospitals
    • Specialty Clinics
    • Cancer Treatment Centers
    • Research Institutes
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa
  • Company Profile:
    • Novartis International AG
    • Pfizer Inc.
    • Ipsen Biopharmaceuticals, Inc.
    • Endocyte
    • RECORDATI GROUP
    • Camurus AB
    • Endeavor Biomedicines, Inc.
    • Debiopharm International SA

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Pituitary Cancer, By Cancer Type
    • Market Pituitary Cancer, By Hormone Type
    • Market Pituitary Cancer, By Treatment Type
    • Market Pituitary Cancer, By Age Group
    • Market Pituitary Cancer, By End User
    • Market Pituitary Cancer, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
  • Increasing Incidence and Prevalence
  • Advancements in Medical Imaging and Diagnostics
  • Increased Research and Development
  • Growing Demand for Personalized Medicine
    • Restraints
  • Limited Awareness and Delayed Diagnosis
  • Lack of Standardized Treatment Guidelines
  • Limited Treatment Options for Aggressive Pituitary Cancers
  • Challenges in Drug Development
    • Opportunities
  • Development of Targeted Therapies
  • Combination Therapies
  • Advancements in Surgical Techniques
  • Development of Novel Imaging Modalities
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Pituitary Cancer Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Pituitary Cancer Market, By Cancer Type, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • Pituitary Adenoma (Benign Tumor)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
  • Pituitary Carcinoma (Malignant Tumor)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

6. Pituitary Cancer Market, By Hormone Type, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • Prolactinoma
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
  • Growth Hormone-Secreting Tumor (Acromegaly)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
  • Adrenocorticotropic Hormone-Secreting Tumor (Cushing's Disease)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
  • Thyroid-Stimulating Hormone-Secreting Tumor (TSHoma)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
  • Gonadotropin-Secreting Tumor
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)

7. Pituitary Cancer Market, By Treatment Type, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023and 2032 (%)
    • Y-o-Y Growth Analysis, 2021- 2032
    • Segment Trends
  • Surgery
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
  • Radiation Therapy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
  • Medications(e.g., dopamine agonists, somatostatin analogs, hormone replacement therapy)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
  • Targeted Therapy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
  • Chemotherapy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)

8. Pituitary Cancer Market, By Age Group, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • Pediatric
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
  • Adult
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)

9. Pituitary Cancer Market, By End User, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
  • Specialty Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
  • Cancer Treatment Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
  • Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)

10. Pituitary Cancer Market, By Region, 2020-2032, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Country, 2023and 2032 (%)
    • Y-o-Y Growth Analysis, For Country 2021-2032
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Hormone Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Hormone Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Hormone Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Hormone Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East & Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Hormone Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
  • GCC
  • Israel
  • North Africa
  • Central Africa
  • Rest of Middle East & Africa

11. Competitive Landscape

  • Novartis International AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Pfizer Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Ipsen Biopharmaceuticals, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Endocyte
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • RECORDATI GROUP
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Camurus AB
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Endeavor Biomedicines, Inc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Debiopharm International SA
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

12. Section

  • Research Methodology
  • About us